MYCOBACTERIUM ABSCESSUS INFECTION
Clinical trials for MYCOBACTERIUM ABSCESSUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new MYCOBACTERIUM ABSCESSUS INFECTION trials appear
Sign up with your email to follow new studies for MYCOBACTERIUM ABSCESSUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare lung infection: epetraborole trial begins
Disease control Recruiting nowThis study tests a drug called epetraborole for people with a chronic lung infection caused by Mycobacterium abscessus. About 84 adults will take either a low or high dose of the drug or a placebo for 84 days. Researchers will check if symptoms improve and if the infection clears…
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Your home water may hide a lung infection risk for cystic fibrosis patients
Knowledge-focused Recruiting nowThis study is investigating whether germs called non-tuberculous mycobacteria (NTM) found in home water systems and dust can cause lung infections in people with cystic fibrosis. Researchers will collect samples from the homes of 120 CF patients—some with NTM infections and some …
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Sponsor: Research Center Borstel • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC